科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/07 | 4,675 | 4,695 | 4,655 | 4,670 | -75 | -1.6% | 93,800 |
2020/10/06 | 4,765 | 4,770 | 4,695 | 4,745 | +30 | +0.6% | 96,100 |
2020/10/05 | 4,720 | 4,800 | 4,705 | 4,715 | +5 | +0.1% | 95,300 |
2020/10/02 | 4,830 | 4,865 | 4,700 | 4,710 | - | - | 149,300 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 4,910 | 4,955 | 4,820 | 4,820 | -95 | -1.9% | 108,200 |
2020/09/29 | 4,880 | 4,940 | 4,830 | 4,915 | -35 | -0.7% | 125,400 |
2020/09/28 | 4,970 | 4,980 | 4,885 | 4,950 | +85 | +1.7% | 127,300 |
2020/09/25 | 4,890 | 4,910 | 4,845 | 4,865 | -15 | -0.3% | 102,500 |
2020/09/24 | 4,840 | 4,890 | 4,835 | 4,880 | +30 | +0.6% | 96,200 |
2020/09/23 | 4,900 | 4,925 | 4,840 | 4,850 | -55 | -1.1% | 191,700 |
2020/09/18 | 4,870 | 4,920 | 4,840 | 4,905 | +45 | +0.9% | 284,300 |
2020/09/17 | 4,785 | 4,865 | 4,785 | 4,860 | +65 | +1.4% | 137,000 |
2020/09/16 | 4,805 | 4,840 | 4,785 | 4,795 | -25 | -0.5% | 117,400 |
2020/09/15 | 4,830 | 4,840 | 4,780 | 4,820 | -15 | -0.3% | 130,200 |
2020/09/14 | 4,790 | 4,905 | 4,790 | 4,835 | +65 | +1.4% | 141,100 |
2020/09/11 | 4,730 | 4,810 | 4,700 | 4,770 | +50 | +1.1% | 149,700 |
2020/09/10 | 4,715 | 4,745 | 4,675 | 4,720 | +40 | +0.9% | 139,000 |
2020/09/09 | 4,665 | 4,685 | 4,575 | 4,680 | -195 | -4% | 392,800 |
2020/09/08 | 4,825 | 4,880 | 4,810 | 4,875 | +50 | +1% | 71,800 |
2020/09/07 | 4,815 | 4,845 | 4,805 | 4,825 | -35 | -0.7% | 167,800 |
2020/09/04 | 4,880 | 4,880 | 4,825 | 4,860 | -45 | -0.9% | 102,100 |
2020/09/03 | 4,965 | 4,965 | 4,875 | 4,905 | -20 | -0.4% | 94,300 |
2020/09/02 | 4,930 | 4,930 | 4,840 | 4,925 | -30 | -0.6% | 143,000 |
2020/09/01 | 4,945 | 4,970 | 4,910 | 4,955 | +55 | +1.1% | 108,800 |
2020/08/31 | 4,945 | 4,955 | 4,895 | 4,900 | +10 | +0.2% | 207,000 |
2020/08/28 | 5,000 | 5,020 | 4,840 | 4,890 | -60 | -1.2% | 128,700 |
2020/08/27 | 4,970 | 5,020 | 4,950 | 4,950 | -80 | -1.6% | 111,100 |
2020/08/26 | 5,010 | 5,030 | 4,965 | 5,030 | ±0 | ±0% | 96,800 |
2020/08/25 | 5,070 | 5,090 | 5,030 | 5,030 | -40 | -0.8% | 100,700 |
2020/08/24 | 5,030 | 5,080 | 5,010 | 5,070 | ±0 | ±0% | 64,000 |
2020/08/21 | 5,090 | 5,130 | 5,060 | 5,070 | -10 | -0.2% | 66,400 |
2020/08/20 | 5,010 | 5,110 | 5,000 | 5,080 | ±0 | ±0% | 184,500 |
2020/08/19 | 5,030 | 5,100 | 5,030 | 5,080 | +70 | +1.4% | 118,000 |
2020/08/18 | 5,020 | 5,060 | 5,000 | 5,010 | +30 | +0.6% | 88,800 |
2020/08/17 | 5,050 | 5,050 | 4,980 | 4,980 | -20 | -0.4% | 66,500 |
2020/08/14 | 5,070 | 5,100 | 5,000 | 5,000 | -70 | -1.4% | 155,000 |
2020/08/13 | 5,070 | 5,100 | 5,000 | 5,070 | +40 | +0.8% | 139,600 |
2020/08/12 | 4,980 | 5,060 | 4,980 | 5,030 | +80 | +1.6% | 138,800 |
2020/08/11 | 4,910 | 5,010 | 4,905 | 4,950 | +40 | +0.8% | 144,300 |
2020/08/07 | 4,840 | 4,945 | 4,840 | 4,910 | +60 | +1.2% | 164,400 |
2020/08/06 | 4,880 | 4,910 | 4,810 | 4,850 | -125 | -2.5% | 218,400 |
2020/08/05 | 4,930 | 5,020 | 4,930 | 4,975 | +10 | +0.2% | 167,900 |
2020/08/04 | 4,975 | 5,080 | 4,900 | 4,965 | +95 | +2% | 211,800 |
2020/08/03 | 4,880 | 4,935 | 4,825 | 4,870 | +95 | +2% | 179,300 |
2020/07/31 | 4,910 | 4,940 | 4,750 | 4,775 | -180 | -3.6% | 286,800 |
2020/07/30 | 4,945 | 4,985 | 4,930 | 4,955 | +10 | +0.2% | 82,800 |
2020/07/29 | 4,950 | 4,975 | 4,910 | 4,945 | -50 | -1% | 152,600 |
2020/07/28 | 5,040 | 5,110 | 4,995 | 4,995 | +10 | +0.2% | 134,900 |
2020/07/27 | 4,995 | 5,050 | 4,950 | 4,985 | -65 | -1.3% | 165,700 |
1151~
1200
件表示中 / 3724件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 382,500円 | -6.4% | -71.8% | 4.97% | 42.72倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 372,500円 | +21.7% | +999.9% | 0.00% | 15.60倍 | 5.16倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
東和薬品 | 295,600円 | +7.9% | -3.3% | 2.71% | 8.22倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 202,200円 | +3.1% | -6.5% | 2.37% | 9.38倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム